High pathogenic avian influenza A(H5) viruses of clade 2.3.4.4b in Europe-Why trends of virus evolution are more difficult to predict
Status PubMed-not-MEDLINE Jazyk angličtina Země Velká Británie, Anglie Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
38699215
PubMed Central
PMC11065109
DOI
10.1093/ve/veae027
PII: veae027
Knihovny.cz E-zdroje
- Klíčová slova
- Europe, high pathogenic avian influenza A(H5) viruses, phylodynamics, reassortments, spatial spread,
- Publikační typ
- časopisecké články MeSH
Since 2016, A(H5Nx) high pathogenic avian influenza (HPAI) virus of clade 2.3.4.4b has become one of the most serious global threats not only to wild and domestic birds, but also to public health. In recent years, important changes in the ecology, epidemiology, and evolution of this virus have been reported, with an unprecedented global diffusion and variety of affected birds and mammalian species. After the two consecutive and devastating epidemic waves in Europe in 2020-2021 and 2021-2022, with the second one recognized as one of the largest epidemics recorded so far, this clade has begun to circulate endemically in European wild bird populations. This study used the complete genomes of 1,956 European HPAI A(H5Nx) viruses to investigate the virus evolution during this varying epidemiological outline. We investigated the spatiotemporal patterns of A(H5Nx) virus diffusion to/from and within Europe during the 2020-2021 and 2021-2022 epidemic waves, providing evidence of ongoing changes in transmission dynamics and disease epidemiology. We demonstrated the high genetic diversity of the circulating viruses, which have undergone frequent reassortment events, providing for the first time a complete overview and a proposed nomenclature of the multiple genotypes circulating in Europe in 2020-2022. We described the emergence of a new genotype with gull adapted genes, which offered the virus the opportunity to occupy new ecological niches, driving the disease endemicity in the European wild bird population. The high propensity of the virus for reassortment, its jumps to a progressively wider number of host species, including mammals, and the rapid acquisition of adaptive mutations make the trend of virus evolution and spread difficult to predict in this unfailing evolving scenario.
Avian Virology and Immunology Sciensano Rue Groeselenberg 99 Ukkel 1180 Ukkel Belgium
Croatian Veterinary Institute Poultry Centre Heinzelova 55 Zagreb 10000 Croatia
Department of Animal Health State Veterinary Institute Pod Dráhami 918 Zvolen 96086 Slovakia
Department of Microbiology National Veterinary Institute Travvägen 20 Uppsala 75189 Sweden
Department of Viroscience Erasmus MC Dr Molewaterplein 40 Rotterdam 3015 GD The Netherlands
European Centre for Disease Prevention and Control Gustav 3 s boulevard 40 Solna 169 73 Sweden
European Food Safety Authority Via Carlo Magno 1A Parma 43126 Italy
Icelandic Food and Veterinary Authority Austurvegur 64 Selfoss 800 Iceland
Institute for Diagnosis and Animal Health Str Dr Staicovici 63 Bucharest 050557 Romania
National Centre for Laboratory Research and Risk Assessment Kreutzwaldi 30 Tartu 51006 Estonia
National Food and Veterinary Risk Assessment Institute Kairiukscio str 10 Vilnius 08409 Lithuania
Republican Center for Veterinary Diagnostics 3 street Murelor Chisinau 2051 Republic of Moldova
Zobrazit více v PubMed
Abed Y., Goyette N., and Boivin G. (2005) ‘Generation and Characterization of Recombinant Influenza A (H1N1) Viruses Harboring Amantadine Resistance Mutations’, Antimicrobial Agents And Chemotherapy, 49: 556–9. PubMed PMC
Abolnik C. et al. (2022) ‘Wild Bird Surveillance in the Gauteng Province of South Africa during the High-Risk Period for Highly Pathogenic Avian Influenza Virus Introduction’, Viruses, 14: 2027. PubMed PMC
Adams S. E. et al. (2019) ‘Effect of Influenza H1N1 Neuraminidase V116A and I117V Mutations on NA Activity and Sensitivity to NA Inhibitors’, Antiviral Research, 169: 104539. PubMed
Adlhoch C. et al. (2022) ‘Avian Influenza Overview June–September 2022’, EFSA Journal, 20: 7597. PubMed PMC
Adlhoch C. et al. (2023a) ‘Avian Influenza Overview April–June 2023’, EFSA Journal. European Food Safety Authority, 21: e08191. 10.2903/J.EFSA.2023.8191 PubMed DOI PMC
Adlhoch C. et al. (2023b) ‘Avian Influenza Overview March–April 2023’, EFSA Journal. European Food Safety Authority, 21: e08039. 10.2903/j.efsa.2023.8039 PubMed DOI PMC
Agüero M. et al. (2023) ‘Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in Farmed Minks, Spain, October 2022’, Eurosurveillance, 28: 2300001. PubMed PMC
Alkie T. N. et al. (2022) ‘A Threat from Both Sides: Multiple Introductions of Genetically Distinct H5 HPAI Viruses into Canada via Both East Asia-Australasia/Pacific and Atlantic Flyways’, Virus Evolution, 8: veac077. PubMed PMC
Ayllon J. et al. (2014) ‘A Single Amino Acid Substitution in the Novel H7N9 Influenza A Virus NS1 Protein Increases CPSF30 Binding and Virulence’, Journal of Virology, 88: 12146–51. PubMed PMC
Bielejec F. et al. (2016) ‘SpreaD3: Interactive Visualization of Spatiotemporal History and Trait Evolutionary Processes’, Molecular Biology and Evolution, 33: 2167–9. PubMed PMC
Bordes L. et al. (2023) ‘Highly Pathogenic Avian Influenza H5N1 Virus Infections in Wild Red Foxes (Vulpes Vulpes) Show Neurotropism and Adaptive Virus Mutations’, Microbiology Spectrum, 11: e02867–22. PubMed PMC
Bortz E. et al. (2011) ‘Host- and Strain-specific Regulation of Influenza Virus Polymerase Activity by Interacting Cellular Proteins’, MBio, 2: 10–128. PubMed PMC
Bourmakina S. V., and García-Sastre A. (2003) ‘Reverse Genetics Studies on the Filamentous Morphology of Influenza A Virus’, Journal of General Virology, 84: 517–27. PubMed
Bragstad K. et al. (2007) ‘First Introduction of Highly Pathogenic H5N1 Avian Influenza A Viruses in Wild and Domestic Birds in Denmark, Northern Europe’, Virology Journal, 4: 1–10. PubMed PMC
Briand F. X. et al. (2022) ‘Multiple Independent Introductions of Highly Pathogenic Avian Influenza H5 Viruses during the 2020-2021 Epizootic in France’, Transboundary and Emerging Diseases, 69: 4028–33. PubMed PMC
Bruno A. et al. (2023) ‘First Case of Human Infection with Highly Pathogenic H5 Avian Influenza a Virus in South America: A New Zoonotic Pandemic Threat for 2023?’, Journal of Travel Medicine, 30: taad032. PubMed PMC
Buranathai C. et al. (2007) ‘Surveillance Activities and Molecular Analysis of H5N1 Highly Pathogenic Avian Influenza Viruses from Thailand, 2004–2005’, Avian Diseases, 51: 194–200. PubMed
Bussey K. A. et al. (2010) ‘PB2 Residue 271 Plays A Key Role in Enhanced Polymerase Activity of Influenza A Viruses in Mammalian Host Cells’, Journal of Virology, 84: 4395–406. PubMed PMC
Caliendo V. et al. (2022) ‘Transatlantic Spread of Highly Pathogenic Avian Influenza H5N1 by Wild Birds from Europe to North America in 2021’, Scientific Reports, 12. PubMed PMC
Campbell P. J. et al. (2014) ‘The M Segment of the 2009 Pandemic Influenza Virus Confers Increased Neuraminidase Activity, Filamentous Morphology, and Efficient Contact Transmissibility to A/Puerto Rico/8/1934-Based Reassortant Viruses’, Journal of Virology, 88: 3802–14. PubMed PMC
Chen H. et al. (2006) ‘Properties and Dissemination of H5N1 Viruses Isolated during an Influenza Outbreak in Migratory Waterfowl in Western China’, Journal of Virology, 80: 5976–83. PubMed PMC
Chen L. M. et al. (2012) ‘In Vitro Evolution of H5N1 Avian Influenza Virus toward Human-type Receptor Specificity’, Virology, 422: 105–13. PubMed PMC
Chernomor O. et al. (2014) ‘Split Diversity in Constrained Conservation Prioritization Using Integer Linear Programming’, Methods in Ecology and Evolution, 6: 83–91. PubMed PMC
Chestakova I. V. et al. (2023) ‘High Number of HPAI H5 Virus Infections and Antibodies in Wild Carnivores in the Netherlands, 2020-2022’, Emerg Microbes Infect. 12: 2270068. PubMed PMC
Cheung C. L. et al. (2006) ‘Distribution of Amantadine-resistant H5N1 Avian Influenza Variants in Asia’, Journal of Infectious Diseases, 193: 1626–9. PubMed
Chizhmakov I. V. et al. (2003) ‘Differences in Conductance of M2 Proton Channels of Two Influenza Viruses at Low and High pH’, The Journal of Physiology, 546: 427–38. PubMed PMC
Domańska-Blicharz K. et al. (2023) ‘Outbreak of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Virus in Cats, Poland, June to July 2023’, Eurosurveillance, 28: 2300366. PubMed PMC
Drummond A. J., and Rambaut A. (2007) ‘BEAST: Bayesian Evolutionary Analysis by Sampling Trees’, BMC Evolutionary Biology, 7: 214. PubMed PMC
Du W. et al. (2018) ‘Substrate Binding by the Second Sialic Acid-Binding Site of Influenza A Virus N1 Neuraminidase Contributes to Enzymatic Activity’, Journal of Virology, 92: 10–128. PubMed PMC
Du W. et al. (2021) ‘Second Sialic Acid-binding Site of Influenza A Virus Neuraminidase: Binding Receptors for Efficient Release’, The FEBS Journal, 288: 5598–612. PubMed PMC
Elgendy E. M. et al. (2017) ‘Identification of Polymerase Gene Mutations that Affect Viral Replication in H5N1 Influenza Viruses Isolated from Pigeons’, Journal of General Virology, 98: 6–17. PubMed
Elleman C. J., and Barclay W. S. (2004) ‘The M1 Matrix Protein Controls the Filamentous Phenotype of Influenza A Virus’, Virology, 321: 144–53. PubMed
Engelsma M. et al. (2022) ‘Multiple Introductions of Reassorted Highly Pathogenic Avian Influenza H5Nx Viruses Clade 2.3.4.4b Causing Outbreaks in Wild Birds and Poultry in the Netherlands, 2020-2021’, Microbiology Spectrum, 10: e02499–21. PubMed PMC
Floyd T. et al. (2021) ‘Encephalitis and Death in Wild Mammals at a Rehabilitation Center after Infection with Highly Pathogenic Avian Influenza A(H5N8) Virus’, Emerging Infectious Diseases, 27: 2856–63. PubMed PMC
Food Safety Authority, E., Adlhoch C. et al. (2023) ‘Avian Influenza Overview September – December 2022’, EFSA Journal, 21: e07786. PubMed PMC
Fornek J. L. et al. (2009) ‘A Single-amino-acid Substitution in A Polymerase Protein of an H5N1 Influenza Virus Is Associated with Systemic Infection and Impaired T-cell Activation in Mice’, Journal of Virology, 83: 11102–15. PubMed PMC
Fouchier R. A. M. et al. (2005) ‘Characterization of A Novel Influenza A Virus Hemagglutinin Subtype (H16) Obtained from Black-headed Gulls’, Journal of Virology, 79: 2814–22. PubMed PMC
Fusaro A. et al. (2019)Disentangling the Role of Africa in the Global Spread of H5 Highly Pathogenic Avian Influenza, Nature Communications, 10: 5310. PubMed PMC
Gabriel G. et al. (2005) ‘The Viral Polymerase Mediates Adaptation of an Avian Influenza Virus to a Mammalian Host’, The Proceedings of the National Academy of Sciences of the United States of America, 102: 18590–5. PubMed PMC
Gabriel G., Herwig A., and Klenk H. D. (2008) ‘Interaction of Polymerase Subunit PB2 and NP with Importin Alpha1 Is A Determinant of Host Range of Influenza A Virus’, PLoS Pathogens, 4: e11. PubMed PMC
Gao Y. et al. (2009) ‘Identification of Amino Acids in HA and PB2 Critical for the Transmission of H5N1 Avian Influenza Viruses in a Mammalian Host’, PLoS Pathogens, 5: e1000709. PubMed PMC
Gao W. et al. (2019) ‘Prevailing I292V PB2 Mutation in Avian Influenza H9N2 Virus Increases Viral Polymerase Function and Attenuates IFN-β Induction in Human Cells’, Journal of General Virology, 100: 1273–81. PubMed PMC
Govorkova E. A. et al. (2022) ‘Global Update on the Susceptibilities of Human Influenza Viruses to Neuraminidase Inhibitors and the Cap-dependent Endonuclease Inhibitor Baloxavir, 2018-2020’, Antiviral Research, 200: 105281. PubMed PMC
Grant M. et al. (2022) ‘Highly Pathogenic Avian Influenza (HPAI H5Nx, Clade 2.3.4.4.b) In Poultry and Wild Birds in Sweden: Synopsis of the 2020–2021 Season’, Veterinary Sciences, 9: 344. PubMed PMC
Gubareva L. V. et al. (2017) ‘Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins’, The Journal of Infectious Diseases, 216: S566–S574. PubMed PMC
Hagag N. M. et al. (2022) ‘Molecular Epidemiology and Evolutionary Analysis of Avian Influenza A(H5) Viruses Circulating in Egypt, 2019-2021’, Viruses, 14: 1758. PubMed PMC
Hatta H. et al. (2001) ‘Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses’, Science, 293: 1840–2. PubMed
Hatta M. et al. (2007) ‘Growth of H5N1 Influenza A Viruses in the Upper Respiratory Tracts of Mice’, PLoS Pathogens, 3: 1374–9. PubMed PMC
He G. et al. (2008) ‘Amantadine-resistance among H5N1 Avian Influenza Viruses Isolated in Northern China’, Antiviral Research, 77: 72–6. PubMed
Herfst S. et al. (2012) ‘Airborne Transmission of Influenza A/H5N1 Virus between Ferrets’, Science, 336: 1534–41. PubMed PMC
Hoffmann T. W. et al. (2012) ‘Length Variations in the NA Stalk of an H7N1 Influenza Virus Have Opposite Effects on Viral Excretion in Chickens and Ducks’, Journal of Virology, 86: 584–8. PubMed PMC
Hu M. et al. (2016) ‘Amino Acid Substitutions V63I or A37S/I61T/V63I/V100A in the PA N-terminal Domain Increase the Virulence of H7N7 Influenza A Virus’, Scientific Reports, 6: 1–11. PubMed PMC
Hu M. et al. (2017a) ‘PA Nsubstitutions A37S, A37S/I61T and A37S/V63I Attenuate the Replication of H7N7 Influenza A Virus by Impairing the Polymerase and Endonuclease Activities’, Journal of General Virology, 98: 364–73. PubMed
Hu M.SS et al. (2017b) ‘PB2 Substitutions V598T/I Increase the Virulence of H7N9 Influenza A Virus in Mammals’, Virology, 501: 92–101. PubMed
Human Infection Caused by Avian Influenza A (H5N1) - Chile [WWW Document], (n.d.) <https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON461> Accessed 8 Aug 2023.
Hurt A. C. et al. (2011) ‘Increased Detection in Australia and Singapore of a Novel Influenza a(H1N1)2009 Variant with Reduced Oseltamivir and Zanamivir Sensitivity Due to a S247N Neuraminidase Mutation’, Eurosurveillance, 16: 19884. PubMed
Ilyushina N. A., Govorkova E. A., and Webster R. G. (2005) ‘Detection of Amantadine-resistant Variants among Avian Influenza Viruses Isolated in North America and Asia’, Virology, 341: 102–6. PubMed
Imai H. et al. (2010) ‘The HA and NS Genes of Human H5N1 Influenza A Virus Contribute to High Virulence in Ferrets’, PLoS Pathogens, 6: e1001106. PubMed PMC
Investigation into the Risk to Human Health of Avian Influenza (influenza A H5N1) in England: Technical Briefing 4 - GOV.UK [WWW Document], (n.d.) <https://www.gov.uk/government/publications/avian-influenza-influenza-a-h5n1-technical-briefings/investigation-into-the-risk-to-human-health-of-avian-influenza-influenza-a-h5n1-in-england-technical-briefing-4> Accessed 21 Nov 2023.
Isoda N. et al. (2022) ‘Detection of New H5N1 High Pathogenicity Avian Influenza Viruses in Winter 2021-2022 in the Far East, Which are Genetically Close to Those in Europe’, Viruses, 14: 2168. PubMed PMC
Jackson D. et al. (2008) ‘A New Influenza Virus Virulence Determinant: The NS1 Protein Four C-terminal Residues Modulate Pathogenicity’, The Proceedings of the National Academy of Sciences of the United States of America, 105: 4381–6. PubMed PMC
Jiao P. et al. (2008) ‘A Single-amino-acid Substitution in the NS1 Protein Changes the Pathogenicity of H5N1 Avian Influenza Viruses in Mice’, Journal of Virology, 82: 1146–54. PubMed PMC
Katoh K., and Standley D. M. (2013) ‘MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability’, Molecular Biology and Evolution, 30: 772–80. PubMed PMC
Kim J. H. et al. (2010) ‘Role of Host-specific Amino Acids in the Pathogenicity of Avian H5N1 Influenza Viruses in Mice’, Journal of General Virology, 91: 1284–9. PubMed PMC
King J. et al. (2022) ‘Connect to Protect: Dynamics and Genetic Connections of Highly Pathogenic Avian Influenza Outbreaks in Poultry from 2016 to 2021 in Germany’, Viruses, 14: 1849. PubMed PMC
Kiso M. et al. (2020) ‘Baloxavir Marboxil Treatment of Nude Mice Infected with Influenza A Virus’, The Journal of Infectious Diseases, 221: 1699–702. PubMed PMC
Kode S. S. et al. (2019) ‘A Novel I117T Substitution in Neuraminidase of Highly Pathogenic Avian Influenza H5N1 Virus Conferring Reduced Susceptibility to Oseltamivir and Zanamivir’, Veterinary Microbiology, 235: 21–4. PubMed
Kuo R.-L., and Krug R. M. (2009) ‘Influenza a Virus Polymerase Is an Integral Component of the CPSF30-NS1A Protein Complex in Infected Cells’, Journal of Virology, 83: 1611–6. PubMed PMC
Labadie K. et al. (2007) ‘Host-range Determinants on the PB2 Protein of Influenza A Viruses Control the Interaction between the Viral Polymerase and Nucleoprotein in Human Cells’, Virology, 362: 271–82. PubMed
Lan Y. et al. (2010) ‘A Comprehensive Surveillance of Adamantane Resistance among Human Influenza A Virus Isolated from Mainland China between 1956 and 2009’, Antiviral Therapy, 15: 853–9. PubMed
Le Q. M. et al. (2009) ‘Selection of H5N1 Influenza Virus PB2 during Replication in Humans’, Journal of Virology, 83: 5278–81. PubMed PMC
Lee D. H. et al. (2017) ‘Evolution, Global Spread, and Pathogenicity of Highly Pathogenic Avian Influenza H5Nx Clade 2.3.4.4’, Journal of Veterinary Science, 18: 269–80. PubMed PMC
Leguia M. et al. (2023) ‘Highly Pathogenic Avian Influenza A (H5N1) in Marine Mammals and Seabirds in Peru’, Nat Commun. 14: 5489. PubMed PMC
Lemey P. et al. (2009) ‘Bayesian Phylogeography Finds Its Roots’, PLoS Computational Biology, 5: e1000520. PubMed PMC
Letsholo S. L. et al. (2022) ‘Emergence of High Pathogenicity Avian Influenza Virus H5N1 Clade 2.3.4.4b In Wild Birds and Poultry in Botswana’, Viruses, 14: 2601. PubMed PMC
Lewis N. S. et al. (2021) ‘Emergence and Spread of Novel H5N8, H5N5 and H5N1 Clade 2.3.4.4 Highly Pathogenic Avian Influenza in 2020’, Emerging Microbes & Infections, 10: 148–51. PubMed PMC
Leyson C. M. et al. (2021) ‘Multiple Gene Segments are Associated with Enhanced Virulence of Clade 2.3.4.4 H5N8 Highly Pathogenic Avian Influenza Virus in Mallards’, Journal of Virology, 95: 10–128. PubMed PMC
Li K. S. et al. (2004) ‘Genesis of a Highly Pathogenic and Potentially Pandemic H5N1 Influenza Virus in Eastern Asia’, Nature, 430: 209–13. PubMed
Li Z. et al. (2005) ‘Molecular Basis of Replication of Duck H5N1 Influenza Viruses in a Mammalian Mouse Model’, Journal of Virology, 79: 12058–64. PubMed PMC
Li J. et al. (2009) ‘Single Mutation at the Amino Acid Position 627 of PB2 that Leads to Increased Virulence of an H5N1 Avian Influenza Virus during Adaptation in Mice Can Be Compensated by Multiple Mutations at Other Sites of PB2’, Virus Research, 144: 123–9. PubMed
Li J. et al. (2018) ‘Three Amino Acid Substitutions in the NS1 Protein Change the Virus Replication of H5N1 Influenza Virus in Human Cells’, Virology, 519: 64–73. PubMed
Lindh E. et al. (2023) ‘Highly Pathogenic Avian Influenza A(H5N1) Virus Infection on Multiple Fur Farms in the South and Central Ostrobothnia Regions of Finland, July 2023’, Eurosurveillance, 28: 2300400. PubMed PMC
Lo F. T. et al. (2022) ‘Intercontinental Spread of Eurasian Highly Pathogenic Avian Influenza A(H5N1) to Senegal’, Emerging Infectious Diseases, 28: 234–7. PubMed PMC
The Global Consortium for H5N8 and Related Influenza, Lycett S. J. et al. (2016) ‘Role for Migratory Wild Birds in the Global Spread of Avian Influenza H5N8’, Science, 354: 213–7. PubMed PMC
Lycett S. J. et al. (2020) ‘Genesis and Spread of Multiple Reassortants during the 2016/2017 H5 Avian Influenza Epidemic in Eurasia’, The Proceedings of the National Academy of Sciences of the United States of America, 117: 20814–25. PubMed PMC
Madslien K. et al. (2021) ‘First Detection of Highly Pathogenic Avian Influenza Virus in Norway’, BMC Veterinary Research, 17: 218. PubMed PMC
Makalo M. R. J. et al. (2022) ‘Highly Pathogenic Avian Influenza (A/H5N1) Virus Outbreaks in Lesotho, May 2021’, Emerging Microbes & Infections, 11: 757–60. PubMed PMC
Manzoor R. et al. (2009) ‘PB2 Protein of a Highly Pathogenic Avian Influenza Virus Strain A/chicken/Yamaguchi/7/2004 (H5N1) Determines Its Replication Potential in Pigs’, Journal of Virology, 83: 1572–8. PubMed PMC
Mehle A., and Doudna J. A. (2008) ‘Inhibitory Activity Restricts the Function of an Avian-like Influenza Polymerase in Primate Cells’, Cell Host & Microbe, 4: 111–22. PubMed PMC
Meseko C. et al. (2023) ‘The Evolution of Highly Pathogenic Avian Influenza A (H5) in Poultry in Nigeria, 2021–2022’, Viruses, 15: 1387. PubMed PMC
Minin V. N., and Suchard M. A. (2008) ‘Counting Labeled Transitions in Continuous-time Markov Models of Evolution’, Journal of Mathematical Biology, 56: 391–412. PubMed
More S. et al. (2017) ‘Avian Influenza’, EFSA Journal. European Food Safety Authority, 15: e04991. PubMed PMC
Moreno A. et al. (2023) ‘Asymptomatic Infection with Clade 2.3.4.4b Highly Pathogenic Avian Influenza A(H5N1) in Carnivore Pets, Italy, April 2023’, Eurosurveillance, 28: 2300441. PubMed PMC
Munier S. et al. (2010) ‘A Genetically Engineered Waterfowl Influenza Virus with A Deletion in the Stalk of the Neuraminidase Has Increased Virulence for Chickens’, Journal of Virology, 84: 940–52. PubMed PMC
Nagy A., Černíková L., and Stará M. (2022) ‘A New Clade 2.3.4.4b H5N1 Highly Pathogenic Avian Influenza Genotype Detected in Europe in 2021’, Archives of Virology, 167: 1455–9. PubMed
Nguyen L.-T. et al. (2015) ‘IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-likelihood Phylogenies’, Molecular Biology and Evolution, 32: 268–74. PubMed PMC
European Food Safety Authority, European Centre for Disease Prevention and Control, European Union Reference Laboratory for Avian Influenza, Adlhoch C. et al. (2023) ‘Avian Influenza Overview December 2022–March 2023’, EFSA Journal. European Food Safety Authority, 21: e07917. PubMed PMC
Oliver I. et al. (2022) ‘A Case of Avian Influenza A(H5N1) in England, January 2022’, Eurosurveillance, 27: 2200061. PubMed PMC
Olsen B. et al. (2006) ‘Global Patterns of Influenza a Virus in Wild Birds’, Science, 312: 384–8. PubMed
Ouoba L. B. et al. (2022) ‘Emergence of a Reassortant 2.3.4.4b Highly Pathogenic H5N1 Avian Influenza Virus Containing H9N2 PA Gene in Burkina Faso, West Africa, in 2021’, Viruses, 14: 1901. PubMed PMC
Pinto R. M.s et al. (2022) ‘Zoonotic Avian Influenza Viruses Evade Human BTN3A3 Restriction’, Nature, 619: 338–47. PubMed
Pinto R. M. et al. (2023) ‘BTN3A3 Evasion Promotes the Zoonotic Potential of Influenza A Viruses’, Nature, 619: 338–47. PubMed
Pohlmann A. et al. (2022) ‘Has Epizootic Become Enzootic? Evidence for a Fundamental Change in the Infection Dynamics of Highly Pathogenic Avian Influenza in Europe, 2021’, MBio, 13: e00609–22. PubMed PMC
Puthavathana P. et al. (2005) ‘Molecular Characterization of the Complete Genome of Human Influenza H5N1 Virus Isolates from Thailand’, Journal of General Virology, 86: 423–33. PubMed
Rameix-Welti M.-A. et al. (2009) ‘Avian Influenza A Virus Polymerase Association with Nucleoprotein, but Not Polymerase Assembly, Is Impaired in Human Cells during the Course of Infection’, Journal of Virology, 83: 1320–31. PubMed PMC
Richard M. et al. (2017) ‘Mutations Driving Airborne Transmission of A/H5N1 Virus in Mammals Cause Substantial Attenuation in Chickens Only When Combined’, Scientific Reports, 71: 1–13. PubMed PMC
Rosone F. et al. (2023) ‘Seroconversion of a Swine Herd in a Free-Range Rural Multi-Species Farm against HPAI H5N1 2.3.4.4b Clade Virus’, Microorganisms, 11: 1162. PubMed PMC
Sagong M. et al. (2022) ‘Emergence of Clade 2.3.4.4b Novel Reassortant H5N1 High Pathogenicity Avian Influenza Virus in South Korea during Late 2021’, Transboundary and Emerging Diseases, 69: e3255–60. PubMed
Salaheldin A. H. et al. (2022) ‘Isolation of Genetically Diverse H5N8 Avian Influenza Viruses in Poultry in Egypt, 2019-2021’, Viruses, 14: 1431. PubMed PMC
Salomon R. et al. (2006) ‘The Polymerase Complex Genes Contribute to the High Virulence of the Human H5N1 Influenza Virus Isolate A/Vietnam/1203/04’, The Journal of Experimental Medicine, 203: 689–97. PubMed PMC
Samson M. et al. (2014) ‘Characterization of Drug-Resistant Influenza Virus A(H1N1) and A(H3N2) Variants Selected in Vitro with Laninamivir’, Antimicrobial Agents and Chemotherapy, 58: 5220–8. PubMed PMC
Sanogo I. N. et al. (2022) ‘Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Virus in Poultry, Benin, 2021’, Emerging Infectious Diseases, 28: 2534–37. PubMed PMC
Scheiffarth G. (2003), Born to fly-Migratory Strategies and Stopover Ecology in the European Wadden Sea of a Long-distance Migrant, the Bar-tailed Godwit (Limosa Lapponica). Faculty of Mathematics and Science, Universität Oldenburg. <http://oops.uni-oldenburg.de/198/>
Scholtissek C. et al. (2002) ‘Cooperation between the Hemagglutinin of Avian Viruses and the Matrix Protein of Human Influenza A Viruses’, Journal of Virology, 76: 1781–6. PubMed PMC
Shapiro B. et al. (2011) ‘A Bayesian Phylogenetic Method to Estimate Unknown Sequence Ages’, Molecular Biology and Evolution, 28: 879–87. PubMed PMC
Shapiro B., Rambaut A., and Drummond A. J. (2006) ‘Choosing Appropriate Substitution Models for the Phylogenetic Analysis of Protein-Coding Sequences’, Molecular Biology and Evolution, 23: 7–9. PubMed
Shinya K. et al. (2004) ‘PB2 Amino Acid at Position 627 Affects Replicative Efficiency, but Not Cell Tropism, of Hong Kong H5N1 Influenza A Viruses in Mice’, Virology, 320: 258–66. PubMed
Smith G. J. D., and Donis R. O. (2015) ‘Nomenclature Updates Resulting from the Evolution of Avian Influenza A(H5) Virus Clades 2.1.3.2a, 2.2.1, And 2.3.4 During 2013–2014’, Influenza and Other Respiratory Viruses, 9: 271–6. PubMed PMC
Song W. et al. (2014) ‘The K526R Substitution in Viral Protein PB2 Enhances the Effects of E627K on Influenza Virus Replication’, Nature Communications, 5: 1–12. PubMed PMC
Sonnberg S., Webby R. J., and Webster R. G. (2013) ‘Natural History of Highly Pathogenic Avian Influenza H5N1’, Virus Research, 178: 63–77. PubMed PMC
Sorrell E. M. et al. (2010) ‘A 27-Amino-Acid Deletion in the Neuraminidase Stalk Supports Replication of an Avian H2N2 Influenza A Virus in the Respiratory Tract of Chickens’, Journal of Virology, 84: 11831–40. PubMed PMC
Soubies S. M. et al. (2010) ‘Species-specific Contribution of the Four C-terminal Amino Acids of Influenza A Virus NS1 Protein to Virulence’, Journal of Virology, 84: 6733–47. PubMed PMC
Spesock A. et al. (2011) ‘The Virulence of 1997 H5N1 Influenza Viruses in the Mouse Model Is Increased by Correcting a Defect in Their NS1 Proteins’, Journal of Virology, 85: 7048–58. PubMed PMC
Steel J. et al. (2009) ‘Transmission of Influenza Virus in a Mammalian Host Is Increased by PB2 Amino Acids 627K or 627E/701N’, PLoS Pathogens, 5: e1000252. PubMed PMC
Stevens J. et al. (2006) ‘Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus’, Science, 312: 404–10. PubMed
Su Y. et al. (2008) ‘Analysis of a Point Mutation in H5N1 Avian Influenza Virus Hemagglutinin in Relation to Virus Entry into Live Mammalian Cells’, Archives of Virology, 153: 2253–61. PubMed
Subbarao E. K., London W., and Murphy B. R. (1993) ‘A Single Amino Acid in the PB2 Gene of Influenza A Virus Is A Determinant of Host Range’, Journal of Virology, 67: 1761–4. PubMed PMC
Suchard M. A. et al. (2018) ‘Bayesian Phylogenetic and Phylodynamic Data Integration Using BEAST 1.10’, Virus Evolution, 4: vey016. PubMed PMC
Suchard M. A., and Rambaut A. (2009) ‘Many-core Algorithms for Statistical Phylogenetics’, Bioinformatics, 25: 1370–6. PubMed PMC
Suttie A. et al. (2019) ‘Inventory of Molecular Markers Affecting Biological Characteristics of Avian Influenza A Viruses’, Virus Genes, 55: 739–68. PubMed PMC
Swieton E. et al. (2020) ‘Sub-Saharan Africa and Eurasia Ancestry of Reassortant Highly Pathogenic Avian Influenza A(H5N8) Virus, Europe, December 2019 - Volume 26, Number 7—July 2020 - Emerging Infectious Diseases Journal - CDC’, Emerging Infectious Diseases, 26: 1557–61. PubMed PMC
Taft A. S. et al. (2015) ‘Identification of Mammalian-adapting Mutations in the Polymerase Complex of an Avian H5N1 Influenza Virus’, Nature Communications, 6: 7491. PubMed PMC
Tammiranta N. et al. (2023) ‘Highly Pathogenic Avian Influenza A (H5N1) Virus Infections in Wild Carnivores Connected to Mass Mortalities of Pheasants in Finland’, Infection Genetics & Evolution, 111: 105423. PubMed
Thi Hoang D. et al. (2017) ‘UFBoot2: Improving the Ultrafast Bootstrap Approximation’, Molecular Biology and Evolution, 35: 518–22. PubMed PMC
Threat Assessment Brief: First Identification of Human Cases of Avian Influenza A(H5N8) Infection [WWW Document], (n.d.), <https://www.ecdc.europa.eu/en/publications-data/threat-assessment-first-human-cases-avian-influenza-h5n8> Accessed Aug 8 2023.
U.S. Case of Human Avian Influenza A(H5) Virus Reported | CDC Online Newsroom | CDC [WWW Document], (n.d.), <https://www.cdc.gov/media/releases/2022/s0428-avian-flu.html> Accessed Aug 8 2023.
Verhagen J. H., Fouchier R. A. M., and Lewis N. (2021) ‘Highly Pathogenic Avian Influenza Viruses at the Wild–Domestic Bird Interface in Europe: Future Directions for Research and Surveillance’, Viruses, 13: 212. PubMed PMC
Vreman S. et al. (2023) ‘Zoonotic Mutation of Highly Pathogenic Avian Influenza H5N1 Virus Identified in the Brain of Multiple Wild Carnivore Species’, Pathogens, 12: 168. PubMed PMC
Wang W. et al. (2010) ‘Glycosylation at 158N of the Hemagglutinin Protein and Receptor Binding Specificity Synergistically Affect the Antigenicity and Immunogenicity of a Live Attenuated H5N1 A/Vietnam/1203/2004 Vaccine Virus in Ferrets’, Journal of Virology, 84: 6570–7. PubMed PMC
Watanabe Y. et al. (2011) ‘Acquisition of Human-Type Receptor Binding Specificity by New H5N1 Influenza Virus Sublineages during Their Emergence in Birds in Egypt’, PLoS Pathogens, 7: e1002068. PubMed PMC
Webster R. G. et al. (1992) ‘Evolution and Ecology of Influenza A Viruses’, Microbiological Reviews, 56: 152–79. PubMed PMC
Webster R. G., Kawaoka Y., and Bean W. J. (1989) ‘What Is the Potential of Avirulent Influenza Viruses to Complement a Cleavable Hemagglutinin and Generate Virulent Strains?’, Virology, 171: 484–92. PubMed
Wille M. et al. (2011) ‘Extensive Geographic Mosaicism in Avian Influenza Viruses from Gulls in the Northern Hemisphere’, PLoS One, 6: e20664. PubMed PMC
World Health Organization (2021) ‘Antigenic and Genetic Characteristics of Zoonotic Influenza A Viruses and Development of Candidate Vaccine Viruses for Pandemic Preparedness March 2021’.
World Health Organization (2023) ‘Avian Influenza Weekly Update Number 895 - 12 May 2023 - Human Infection with Avian Influenza A(H5) Viruses’.
Xiao C. et al. (2016) ‘B2–588 V Promotes the Mammalian Adaptation of H10N8, H7N9 and H9N2 Avian Influenza Viruses’, Scientific Reports, 6: 19474. PubMed PMC
Xie R. et al. (2023) ‘The Episodic Resurgence of Highly Pathogenic Avian Influenza H5 Virus’, Nature, 622: 810–7. PubMed
Xu G. et al. (2016) ‘Prevailing PA Mutation K356R in Avian Influenza H9N2 Virus Increases Mammalian Replication and Pathogenicity’, Journal of Virology, 90: 8105–14. PubMed PMC
Yamada S. et al. (2006) ‘Haemagglutinin Mutations Responsible for the Binding of H5N1 Influenza A Viruses to Human-type Receptors’, Nature, 444: 378–82. PubMed
Yamayoshi S. et al. (2014) ‘Virulence-Affecting Amino Acid Changes in the PA Protein of H7N9 Influenza A Viruses’, Journal of Virology, 88: 3127–34. PubMed PMC
Yamayoshi S. et al. (2018) ‘Enhanced Replication of Highly Pathogenic Influenza A(H7N9) Virus in Humans’, Emerging Infectious Diseases, 24: 746–50. PubMed PMC
Yang Z. Y. et al. (2007) ‘Immunization by Avian H5 Influenza Hemagglutinin Mutants with Altered Receptor Binding Specificity’, Science, 317: 825–8. PubMed PMC
Ye H. et al. (2022) ‘Divergent Reassortment and Transmission Dynamics of Highly Pathogenic Avian Influenza A(H5N8) Virus in Birds of China during 2021’, Frontiers in Microbiology, 13: 913551. PubMed PMC
Youk S. et al. (2023) ‘H5N1 Highly Pathogenic Avian Influenza Clade 2.3.4.4b In Wild and Domestic Birds: Introductions into the United States and Reassortments, December 2021-April 2022’, Virology, 587: 109860. PubMed
Zhang J. et al. (2018) ‘The D253N Mutation in the Polymerase Basic 2 Gene in Avian Influenza (H9N2) Virus Contributes to the Pathogenesis of the Virus in Mammalian Hosts’, Virologica Sinica, 33: 531–7. PubMed PMC
Zhang G. et al. (2023) ‘Bidirectional Movement of Emerging H5N8 Avian Influenza Viruses between Europe and Asia via Migratory Birds since Early 2020’, Molecular Biology and Evolution, 40: msad019. PubMed PMC
Zhou H. et al. (2009) ‘The Special Neuraminidase Stalk-motif Responsible for Increased Virulence and Pathogenesis of H5N1 Influenza A Virus’, PLoS One, 4: e6277. PubMed PMC
Zhu W. et al. (2015) ‘Residues 41V And/or 210D in the NP Protein Enhance Polymerase Activities and Potential Replication of Novel Influenza (H7N9) Viruses at Low Temperature’, Virology Journal, 12: 1–5. PubMed PMC